A joint report titled “Clinical Trial Opportunities in India” Report was released recently by the PwC India and US-India Chamber of Commerce (USAIC). Key findings of the Report: Clinical trial activity in India was historically low until 2014 due to ..
Month: Current Affairs - May, 2023
Category: Reports & Indexes Current Affairs
The US Food and Drug Administration (FDA) has approved lecanemab, a monoclonal antibody developed by Eisai and Biogen, for the treatment of Alzheimer’s disease. Lecanemab is the second drug to receive approval for the treatment of Alzheimer’s and the first ..
Category: Science & Technology Current Affairs
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the ..
The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has sought the approval of Drugs Controller General of India to begin phase ..
On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes that are conducting the clinical trials of the indigenous vaccine. Currently India ..
Month: Current Affairs - July, 2020
Health and Family Welfare Ministry have issued the Drugs and Clinical Trials Rules, 2019 with a motive to enhance clinical research in the country. The new rules will alter the regulatory landscape for the approval of new drugs and conduct ..